CE认证
水光针
Sunekos Inticare is an injectable medical device by Sunekos, developed by Professional Dietetics for the intimate area with specific therapeutic indications. It is suitable for qualified practitioners treating Vulvo-Vaginal Atrophy (VVA) on the labia minora, labia majora, vestibule, vaginal introitus and vaginal walls. Its patented HY6AA formula combines non-cross-linked low molecular weight hyaluronic acid with a cluster of six amino acids, designed to restructure the extracellular matrix of the mucosal lining and produce a long lasting physiological rehydration, and the product is intended for professional use. It comes as a pack of two 3 ml treatments to be reconstituted.
主要优势： SUNEKOS Inticare
- CE-marked Class III medical device for the intimate area with specific therapeutic indications
- Indicated for the treatment of Vulvo-Vaginal Atrophy (VVA)
- Promotes the restoration of the physiological conditions of elasticity of the soft tissue
- Supports the regeneration of the soft tissue
- Restructures the extracellular matrix of the mucosal lining in the vulvo-vaginal area
- Produces a long lasting physiological rehydration
- Based on the patented HY6AA formula: non-cross-linked low molecular weight hyaluronic acid with six amino acids
- Can be used in combo treatment with CO2 laser, non-fractional radio frequency and carboxytherapy
- High tolerability in preliminary data from a multicentric clinical trial on 85 patients, with no adverse events recorded
适应症与专业用途
主要适应症
- Vulvo-Vaginal Atrophy (VVA)
- Loss of elasticity of the vulvo-vaginal soft tissue
- Degradation of the extracellular matrix of the vulvo-vaginal mucosal lining
- Reduced physiological hydration of the intimate area
专业用途
Sunekos Inticare is a Class III medical device for the intimate area, supplied for professional use only and administered by qualified medical practitioners trained in vulvo-vaginal injection technique. The product is supplied as a pack of two treatments to be reconstituted before use, each combining a 3 ml vial of non-cross-linked low molecular weight hyaluronic acid with a 100 mg bottle of the patented 6AA formula. The treating practitioner determines patient suitability, the areas treated, the injection plane, the dose per point and the session interval. Technique differs by area: the labia majora are treated sub-cutaneously with a fan technique using a 13 mm 30-32 G needle at 0.3 ml per point; the vestibule, introitus and vaginal walls are treated with micro-bolus injections using a 4 mm 30-32 G needle at about 0.03 ml per point, intra-mucosa at 2 mm depth for the introitus and vaginal walls. Aseptic technique applies throughout and any unused reconstituted solution is discarded.
治疗部位
- Labia Minora
- Labia Majora
- Vestibule
- Vaginal Introitus
- Vaginal Walls
适用患者
Sunekos Inticare is intended for adult patients presenting with vulvo-vaginal atrophy, where restoration of mucosal elasticity and physiological hydration is the treatment goal. Suitability, the areas to be treated and the number of sessions are determined by the treating practitioner following clinical assessment. In preliminary data from a multicentric clinical trial, the treatment was evaluated on 85 patients with vulvo-vaginal atrophy using the Likert scale, showed high tolerability and recorded no adverse events.
作用原理： SUNEKOS Inticare
Sunekos Inticare acts by promoting the restoration of the physiological conditions of elasticity and the regeneration of the soft tissue. The patented HY6AA formula combines non-cross-linked low molecular weight hyaluronic acid with a cluster of six amino acids, glycine, L-proline, L-lysine HCl, L-leucine, L-valine and L-alanine, in a specifically balanced solution. The combination is designed to restructure the extracellular matrix of the mucosal lining in the vulvo-vaginal area rather than to add volume, producing a long lasting physiological rehydration of the treated tissue.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 SUNEKOS 产品，来自经过严格审核的供应商，具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地，以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果，并提供专属售后支持，让您安心无忧。
常见问题
What is Sunekos Inticare indicated for?
Sunekos Inticare is a Class III medical device for the intimate area, indicated for the treatment of Vulvo-Vaginal Atrophy (VVA).
Which areas can be treated with Sunekos Inticare?
The labia minora, labia majora, vestibule, vaginal introitus and vaginal walls. Injection technique and dose per point differ by area and are determined by the treating practitioner.
What does Sunekos Inticare contain?
Each treatment combines a 3 ml vial of non-cross-linked low molecular weight hyaluronic acid with a 100 mg bottle of the patented 6AA formula: glycine, L-proline, L-lysine HCl, L-leucine, L-valine and L-alanine, in a specifically balanced solution. The two components are reconstituted before use.
What is the Sunekos Inticare protocol?
The protocol is 3 injections at 21 day intervals. The practitioner sets the areas treated and the dose per point for each patient.
更多产品： Professional Dietetics
生物活化
诊所替代选择
医美护肤
/ 最近浏览
继续浏览
Sunekos Inticare is an injectable medical device by Sunekos, developed by Professional Dietetics for the intimate area with specific therapeutic indications. It is suitable for qualified practitioners treating Vulvo-Vaginal Atrophy (VVA) on the labia minora, labia majora, vestibule, vaginal introitus and vaginal walls. Its patented HY6AA formula combines non-cross-linked low molecular weight hyaluronic acid with a cluster of six amino acids, designed to restructure the extracellular matrix of the mucosal lining and produce a long lasting physiological rehydration, and the product is intended for professional use. It comes as a pack of two 3 ml treatments to be reconstituted.
主要优势： SUNEKOS Inticare
- CE-marked Class III medical device for the intimate area with specific therapeutic indications
- Indicated for the treatment of Vulvo-Vaginal Atrophy (VVA)
- Promotes the restoration of the physiological conditions of elasticity of the soft tissue
- Supports the regeneration of the soft tissue
- Restructures the extracellular matrix of the mucosal lining in the vulvo-vaginal area
- Produces a long lasting physiological rehydration
- Based on the patented HY6AA formula: non-cross-linked low molecular weight hyaluronic acid with six amino acids
- Can be used in combo treatment with CO2 laser, non-fractional radio frequency and carboxytherapy
- High tolerability in preliminary data from a multicentric clinical trial on 85 patients, with no adverse events recorded
适应症与专业用途
主要适应症
- Vulvo-Vaginal Atrophy (VVA)
- Loss of elasticity of the vulvo-vaginal soft tissue
- Degradation of the extracellular matrix of the vulvo-vaginal mucosal lining
- Reduced physiological hydration of the intimate area
专业用途
Sunekos Inticare is a Class III medical device for the intimate area, supplied for professional use only and administered by qualified medical practitioners trained in vulvo-vaginal injection technique. The product is supplied as a pack of two treatments to be reconstituted before use, each combining a 3 ml vial of non-cross-linked low molecular weight hyaluronic acid with a 100 mg bottle of the patented 6AA formula. The treating practitioner determines patient suitability, the areas treated, the injection plane, the dose per point and the session interval. Technique differs by area: the labia majora are treated sub-cutaneously with a fan technique using a 13 mm 30-32 G needle at 0.3 ml per point; the vestibule, introitus and vaginal walls are treated with micro-bolus injections using a 4 mm 30-32 G needle at about 0.03 ml per point, intra-mucosa at 2 mm depth for the introitus and vaginal walls. Aseptic technique applies throughout and any unused reconstituted solution is discarded.
治疗部位
- Labia Minora
- Labia Majora
- Vestibule
- Vaginal Introitus
- Vaginal Walls
适用患者
Sunekos Inticare is intended for adult patients presenting with vulvo-vaginal atrophy, where restoration of mucosal elasticity and physiological hydration is the treatment goal. Suitability, the areas to be treated and the number of sessions are determined by the treating practitioner following clinical assessment. In preliminary data from a multicentric clinical trial, the treatment was evaluated on 85 patients with vulvo-vaginal atrophy using the Likert scale, showed high tolerability and recorded no adverse events.
作用原理： SUNEKOS Inticare
Sunekos Inticare acts by promoting the restoration of the physiological conditions of elasticity and the regeneration of the soft tissue. The patented HY6AA formula combines non-cross-linked low molecular weight hyaluronic acid with a cluster of six amino acids, glycine, L-proline, L-lysine HCl, L-leucine, L-valine and L-alanine, in a specifically balanced solution. The combination is designed to restructure the extracellular matrix of the mucosal lining in the vulvo-vaginal area rather than to add volume, producing a long lasting physiological rehydration of the treated tissue.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 SUNEKOS 产品，具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
What is Sunekos Inticare indicated for?
Sunekos Inticare is a Class III medical device for the intimate area, indicated for the treatment of Vulvo-Vaginal Atrophy (VVA).
Which areas can be treated with Sunekos Inticare?
The labia minora, labia majora, vestibule, vaginal introitus and vaginal walls. Injection technique and dose per point differ by area and are determined by the treating practitioner.
What does Sunekos Inticare contain?
Each treatment combines a 3 ml vial of non-cross-linked low molecular weight hyaluronic acid with a 100 mg bottle of the patented 6AA formula: glycine, L-proline, L-lysine HCl, L-leucine, L-valine and L-alanine, in a specifically balanced solution. The two components are reconstituted before use.
What is the Sunekos Inticare protocol?
The protocol is 3 injections at 21 day intervals. The practitioner sets the areas treated and the dose per point for each patient.
更多产品： Professional Dietetics
查看制造商 →* 专业用途产品。包装可能因批次或市场而异。完整的使用说明和禁忌症请参阅随附的使用说明书。